Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the best fundamentally strong penny stocks to buy according to analysts. On December 19, TheFly reported that Cathie Wood’s ARK Investment has ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the best NASDAQ stocks under $10 to buy. As of December 15, Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) has a ‘Hold’ or equivalent rating from ...

Following a thrilling end to the 2025 season, where Lando Norris secured his first Formula 1 world title in a three-way showdown to the wire, it's time to build up to the new 2026 season. In what is a ...

Next year is going to be a big one for Formula 1. For the first time in quite a while there will be 11 teams on the grid, including new comers Audi and Cadillac. Ford and Honda are also returning as ...

Four of the nation's top retail stores failed to promptly pull contaminated infant formula tied to a dangerous botulism outbreak from their shelves, federal health officials said in warning letters ...

Condé Nast Traveler readers believe this major US city is the end-all-be-all for shopping destinations in the country.

James Chen, CMT is an expert trader, investment adviser, and global market strategist. David Kindness is a Certified Public Accountant (CPA) and an expert in the fields of financial accounting, ...

Daniel Jassy, CFA, is an Investopedia Academy instructor and the founder of SPYderCRusher Research. He contributes to Excel and Algorithmic Trading. What Is the Calculating Compound Annual Growth Rate ...